MonTa Biosciences ApS — Credit Rating and Financial Key Figures
CVR number: 36697016
Diplomvej 377, 2800 Kongens Lyngby
simonjensen@montabiosciences.com
www.montabiosciences.com
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -12 136.62 | 2 130.49 | 1 756.94 | 2 024.63 | 1 479.57 |
| Employee benefit expenses | -3 518.33 | -3 448.56 | -3 081.66 | -3 773.74 | -3 532.81 |
| EBIT | -15 654.95 | -1 318.07 | -1 324.72 | -1 749.10 | -2 053.25 |
| Other financial income | 10.24 | 49.56 | |||
| Other financial expenses | - 792.44 | -1 294.52 | -1 913.96 | -2 841.46 | -3 395.88 |
| Pre-tax profit | -16 447.39 | -2 612.59 | -3 238.68 | -4 580.32 | -5 399.57 |
| Income taxes | 3 154.61 | 4 018.85 | 1 799.54 | 1 301.70 | 1 479.00 |
| Net earnings | -13 292.78 | 1 406.26 | -1 439.14 | -3 278.63 | -3 920.57 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Development expenditure | 9 514.61 | 24 822.05 | 41 297.23 | 58 088.50 | 74 706.57 |
| Intangible assets total | 9 514.61 | 24 822.05 | 41 297.23 | 58 088.50 | 74 706.57 |
| Tangible assets total | |||||
| Investments total | 24.71 | 25.33 | 25.99 | 28.66 | 29.38 |
| Long term receivables total | |||||
| Inventories total | |||||
| Prepayments and accrued income | 56.47 | ||||
| Current other receivables | 314.61 | 5 007.57 | 196.42 | 221.01 | 499.70 |
| Current deferred tax assets | 5 247.82 | 3 367.64 | 3 624.54 | 2 516.44 | 1 213.87 |
| Short term receivables total | 5 562.43 | 8 375.21 | 3 820.96 | 2 737.45 | 1 770.04 |
| Cash and bank deposits | 5 293.45 | 1 793.47 | 4 009.93 | 13 172.01 | 6 877.71 |
| Cash and cash equivalents | 5 293.45 | 1 793.47 | 4 009.93 | 13 172.01 | 6 877.71 |
| Balance sheet total (assets) | 20 395.21 | 35 016.05 | 49 154.10 | 74 026.63 | 83 383.70 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Share capital | 2 629.98 | 2 629.98 | 2 629.98 | 2 629.98 | 2 629.98 |
| Other reserves | 7 421.39 | 19 361.20 | 32 211.84 | 45 309.03 | 58 271.13 |
| Retained earnings | 4 945.78 | -20 286.80 | -31 731.18 | -46 267.51 | -62 508.23 |
| Profit of the financial year | -13 292.78 | 1 406.26 | -1 439.14 | -3 278.63 | -3 920.57 |
| Shareholders equity total | 1 704.38 | 3 110.64 | 1 671.50 | -1 607.12 | -5 527.70 |
| Provisions | 2 093.21 | 1 442.00 | 3 267.00 | 3 842.00 | 3 366.00 |
| Non-current loans from credit institutions | 15 686.30 | 29 924.25 | 43 827.26 | 70 663.15 | 84 054.93 |
| Non-current liabilities total | 15 686.30 | 29 924.25 | 43 827.26 | 70 663.15 | 84 054.93 |
| Current trade creditors | 52.00 | 52.00 | 52.00 | 60.00 | 1 415.10 |
| Short-term deferred tax liabilities | 639.74 | ||||
| Other non-interest bearing current liabilities | 859.32 | 487.17 | 336.34 | 428.86 | 75.37 |
| Current liabilities total | 911.31 | 539.17 | 388.34 | 1 128.60 | 1 490.47 |
| Balance sheet total (liabilities) | 20 395.21 | 35 016.05 | 49 154.10 | 74 026.63 | 83 383.70 |
Try the full version of our system for free
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions
... and more!
No registration needed.